Kathleen C. F. Sheehan

Author

Washington University in St. Louis ORCID

Also Known As

K C F Sheehan, K C Sheehan, K SHEEHAN, K Sheehan, K. C. F. Sheehan, K. Sheehan, KATHLEEN C. SHEEHAN, Kate Sheehan, Kathleen C F Sheehan, Kathleen C Sheehan

Publications

10.9K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis Inserm University of Geneva Centre National de la Recherche Scientifique Monash University

About

Kathleen C. F. Sheehan is an author at Washington University in St. Louis specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	27	8.2K
2	Immunology	23	25	6.5K
3	Cell Biology	16	16	5.1K
4	Allergy	6	6	754
5	Natural Sciences	2	2	81

Kathleen C. F. Sheehan

Publications

10.6K

Citations

H-Index

Page 1

	Year	Citations
Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway Marco Antonio Meraz‐Ríos, J. Michael White, Kathleen C. F. Sheehan, Cell Transcriptional RegulationSignal TransductionSignaling PathwayMolecular PathwayCell Regulation	1996	1.7K
Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses Scott J. Rodig, Marco Antonio Meraz‐Ríos, J. Michael White, Cell InflammationCytokineSignal TransductionAutoimmune DiseaseReceptor Tyrosine Kinase	1998	842
MHC-II neoantigens shape tumour immunity and response to immunotherapy Elise Alspach, Danielle M. Lussier, Alexander P. Miceli, Nature Tumor ImmunologyCancer ImmunosurveillanceMhc-ii NeoantigensImmunologyTumor Immunity	2019	837
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling John R. Teijaro, Cherie Ng, Andrew M. Lee, Science	2013	736
Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice Sharon Erickson, Frédéric J. de Sauvage, Kristine Kikly, Nature InflammationCytokineAutoimmune DiseaseNormal T-cell DevelopmentImmune Cell Development	1994	599
A critical function for type I interferons in cancer immunoediting Gavin P. Dunn, Allen T. Bruce, Kathleen C. F. Sheehan, Nature Immunology Cancer ImmunosurveillanceImmunologyTumor ImmunityPathologyImmunologic Mechanism	2005	593
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang, Cell Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2020	507
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward, Cell Tumor BiologyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunology	2018	407
Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. Kathleen C. F. Sheehan, Nancy H. Ruddle, Robert D. Schreiber The Journal of Immunology ImmunologyPathologyImmunologic MechanismAntigen ProcessingImmune System	1989	380
Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function Jeremy B. Swann, Yoshihiro Hayakawa, Nadeen Zerafa, The Journal of Immunology Nk Cell HomeostasisImmunologyImmunologic MechanismImmunotherapyNatural Killer Cells	2007	325

Page 1